Share on StockTwits

Equities researchers at Piper Jaffray initiated coverage on shares of bluebird bio (NASDAQ:BLUE) in a research report issued on Friday, TheFlyOnTheWall.com reports. The firm set an “overweight” rating on the stock.

In other bluebird bio news, COO Jeffrey T. Walsh unloaded 6,000 shares of the stock on the open market in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $24.23, for a total value of $145,380.00. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

bluebird bio (NASDAQ:BLUE) opened at 25.27 on Friday. bluebird bio has a 1-year low of $17.03 and a 1-year high of $36.25. The stock’s 50-day moving average is $22.08 and its 200-day moving average is $22.33. The company’s market cap is $619.4 million.

bluebird bio (NASDAQ:BLUE) last issued its quarterly earnings data on Tuesday, May 13th. The company reported ($0.44) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.32) by $0.12. The company had revenue of $6.30 million for the quarter, compared to the consensus estimate of $6.23 million. On average, analysts predict that bluebird bio will post $-1.79 earnings per share for the current fiscal year.

Separately, analysts at Zacks upgraded shares of bluebird bio from an “underperform” rating to a “neutral” rating in a research note on Wednesday, May 14th. They now have a $19.90 price target on the stock. One analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus target price of $37.73.

bluebird bio, Inc is a clinical-stage biotechnology company, the Company is focused on transforming the lives of patients with severe genetic and orphan diseases using gene therapy.

The Fly On The Wall

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.